16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Premature pubarche in an infant: nonclassical congenital adrenal hyperplasia or mini-puberty variant?

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction Premature pubarche (PP) is defined as the appearance of pubic hair before 8 yr of age in girls and 9 yr in boys, without other signs of puberty. The appearance of pubarche before one year of life is rare, with few reports in the literature. We present a case of PP in a 7-mo-old infant that was found to be in mini-puberty and also had non-classical congenital adrenal hyperplasia (CAH). Case Report A previously healthy, 7-mo-old male infant presented with a 3-mo history of pubic hair. He was a healthy, term newborn who was born to nonconsanguineous parents, and had appropriate weight and length. Physical examination revealed thick and long pubic hair on the scrotum, without hyperpigmentation or enlargement of the penis (Fig. 1a Fig. 1. A: Pubic hair confined to the scrotum. B: Six months later, pubic hair resolved. ). No other signs of virilization or secondary sexual development were noted. His height (–0.08 SDS) and weight (–0.11 SDS) were normal for his age and appropriate for midparental height, with no apparent acceleration in growth rate. Laboratory data obtained the same day showed normal dehydroepiandrosterone sulfate (DHEA-S) and androstenedione levels, as well as negative results for β-subunit of human chorionic gonadotropin (βhCG), alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA). Basal plasma LH concentration was 1.5 mIU/ml (Reference value [RV]: 0.02–0.3 mIU/ml), testosterone was 25.2 ng/dl (RV: < 2.5 ng/dl), and 17-OH-progesterone was 2.48 ng/ml (RV: < 1.1 ng/ml) (gas chromatography/mass spectrometry). Bone age was equal to his chronological age. Abdominal ultrasound did not show any masses, and demonstrated normal adrenal glands. Due to his elevated 17-OH-progesterone concentration, analysis of the CYP21A2 gene was performed and showed a homozygous variant of p.Val281Leu. Genetic studies of the parents were not done. After an observation period of 6 months, pubarche spontaneously resolved (Fig. 1b), with no other signs of virilization, and growth velocity remained normal. Discussion As noted, PP is defined as the appearance of pubic hair before 8 yr of age in girls and 9 yr in boys, without other signs of puberty. It more frequently occurs between the ages of 6 to 8 yr, with a clear predominance in girls (1). Pubarche in the first year of life is rare, with few reports and little description in the literature. It is thought to be benign because most cases resolve spontaneously; however, long-term follow-up is necessary to determine the etiology. When clinical signs of pubarche are noted, careful physical examination and analysis of the growth chart should be performed. The initial biochemical evaluation must include the determination of sex steroids and 17-OH-progesterone levels. If testosterone concentrations are elevated, βhCG and an abdominal and pelvic ultrasound should be evaluated (2). The diagnosis of premature pubarche is based on the exclusion of other causes of prepubertal hyperandrogenism (3), and the etiology in infants remains unknown. A possible explanation might be the early physiological rise of testosterone in mini-puberty (4), which is not accompanied by other signs of secondary sexual development (axillary hair or odor, advanced bone age, and/or acceleration of the growth rate) and resolves spontaneously. Among the pathological causes that may initially present as premature pubarche, classic or non-classical CAH, precocious puberty, virilizing tumors, and exogenous exposure must be excluded. Classically, these conditions present with other findings such as clitoromegaly, increased penile length, advanced bone age, and growth acceleration. Despite the fact that this case did not present with other clinical findings of CAH, elevated 17-OH-progesterone concentration suggested non-classical CAH. Molecular study showed a homozygous variant of p.Val281Leu. This pathogenic variant has been described in patients with non-classical CAH (5); however, to our knowledge, this variant has not been described in infants that present with premature pubarche. As this boy’s phenotype resolved in time and did not present other features of CAH, the clinical significance of this genotype is not clear. Treatment is not always indicated in patients with non-classical CAH, unless they are symptomatic. Symptomatic hyperandrogenism can be reduced with low-dose glucocorticoids, as in children with early onset and rapid progression of pubic and body hair, rapid growth, and/or skeletal advancement. Conflict of Interest: The authors have no relevant conflict of interest.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche.

          Because precocious pubarche (PP) reveals late-onset congenital adrenal hyperplasia (LO-CAH) in 5 to 20% of cases, an adrenal stimulation test is recommended in all patients presenting with it. This test is stressful and expensive, and results are normal in more than 80% of cases. Our objective was to identify clinical and plasma predictors of LO-CAH among patients presenting with PP. We conducted a retrospective cohort study that included all patients seen for PP at our hospital between 1999 and 2006 (n = 238). All had undergone an ACTH test. LO-CAH was defined by a post-ACTH 17-hydroxyprogesterone (17-OHP) plasma level greater than 10 ng/ml and confirmed by mutational analysis of the CYP21 gene. The association of standard clinical and laboratory indicators with LO-CAH was assessed. Ten (4%) of 238 patients had LO-CAH. Basal 17-OHP, Delta4-androstenedione, and testosterone plasma levels were significantly higher in these patients. A 2-ng/ml threshold for basal 17-OHP plasma levels offered 100% (95% CI, 69-100) sensitivity for the diagnosis of LO-CAH and 99% (95% CI, 96-100) specificity. We identified three plasma predictors of LO-CAH in patients presenting with PP. A selective strategy based on a 2-ng/ml basal 17-OHP plasma level threshold would have safely avoided 99% of the unnecessary ACTH tests among our patients.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.

            To analyze the mutational spectrum of steroid 21-hydroxylase (CYP21) and the genotype- phenotype correlation in patients with congenital adrenal hyperplasia (CAH) registered in the Middle European Society for Pediatric Endocrinology CAH database, and to design a reliable and rational approach for CYP21 mutation detection in Middle European populations. Molecular analysis of the CYP21 gene was performed in 432 CAH patients and 298 family members. Low-resolution genotyping was performed to detect the eight most common point mutations. High-resolution genotyping, including Southern blotting and sequencing was performed to detect CYP21 gene deletions, conversions, point mutations or other sequence changes. CYP21 gene deletion and In2 and Ile172Asn mutation accounted for 72.7% of the affected alleles in the whole study group. A good genotype-phenotype correlation was observed, with the exception of Ile172Asn and Pro30Leu mutations. In 37% of patients low resolution genotyping could not identify the causative mutation or distinguish homozygosity from hemizygosity. Using high-resolution genotyping, the causative mutations could be identified in 341 out of 348 analyzed patients. A novel mutation Gln315Stop was found in one simple virilising CAH (SV-CAH) patient from Austria. In the remaining seven patients polymorphisms were identified as the leading sequence alteration. The presence of elevated basal and ACTH-stimulated 17-hydroxyprogesterone, premature pubarche, advanced bone age and clitoral hypertrophy directly implicated Asn493Ser polymorphism in the manifestation of nonclassical- (NC) and even SV-CAH. By genotyping for the most common point mutations, CYP21 gene deletion/conversion and the 8 bp deletion in exon 3, it should be possible to identify the mutation in 94-99% of the diseased alleles in any investigated Middle European population. In patients with a mild form of the disease and no detectable mutation CYP21 gene polymorphisms should be considered as a plausible disease-causing mutation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Premature Pubarche

                Bookmark

                Author and article information

                Journal
                Clin Pediatr Endocrinol
                Clin Pediatr Endocrinol
                CPE
                Clinical Pediatric Endocrinology
                The Japanese Society for Pediatric Endocrinology
                0918-5739
                1347-7358
                27 July 2017
                2017
                : 26
                : 3
                : 193-195
                Affiliations
                [1 ] Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
                Article
                2017-0005
                10.1297/cpe.26.193
                5537217
                28804212
                05dbd9a0-a130-4b49-951e-f1bc9919d208
                2017©The Japanese Society for Pediatric Endocrinology

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License.

                History
                : 19 January 2017
                : 20 March 2017
                Categories
                Short Communication

                premature pubarche,infant,precocious puberty
                premature pubarche, infant, precocious puberty

                Comments

                Comment on this article